Suppr超能文献

术后早期降钙素与术前降钙素比值作为散发性甲状腺髓样癌结构复发的预测标志物:一项回顾性研究。

Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study.

机构信息

Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou,  China.

State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou,  China.

出版信息

Front Endocrinol (Lausanne). 2022 Dec 16;13:1094242. doi: 10.3389/fendo.2022.1094242. eCollection 2022.

Abstract

BACKGROUND

Calcitonin (Ctn) is widely used as a marker in the diagnosis, prognosis, and postoperative follow-up of patients with medullary thyroid carcinoma (MTC). The prognostic value of postoperative calcitonin-to-preoperative calcitonin ratio (CR), reflecting the change in Ctn level of response to initial treatment, remains uncertain in long-term disease outcomes. This study aims to determine the cut-off value of CR for predicting structural recurrence and assess the prognostic role of CR in patients with MTC.

METHODS

We retrospectively reviewed patients with MTC in Sun Yat-sen University Cancer Center (SYSUCC) between 2000 and 2022. CR is defined as the ratio of postoperative Ctn level on the day of discharge divided by preoperative Ctn level. In order to determine the optimal cut-off value of CR, the receiver operating characteristic (ROC) analysis was performed. We evaluate the effect of CR on recurrence-free survival (RFS) by using the Kaplan-Meier method and Cox regression analysis. Then, a nomogram based on CR was constructed.

RESULTS

In total, 112 sporadic MTC patients were included in this study. The optimal cut-off value of CR that predicted disease recurrence was 0.125. Patients with CR≥0.125 showed significantly worse RFS than patients with CR <0.125, respectively (3-years RFS rate of 63.1 vs. 94.7%, 5-years RFS rate of 50.7 vs. 90.3%, P < 0.001). In the multivariate analysis, CR was the strongest independent predictor of structural recurrence (HR: 5.050, 95% CI: 2.247-11.349, 0.001). Tumor size (HR: 1.321, 95% CI: 1.010-1.726, =0.042), multifocality (HR: 2.258, 95% CI: 1.008-5.058, =0.048) and metastasized lymph nodes (HR: 3.793, 95% CI: 1.617-8.897, 0.001) were also independent predictors of structural recurrence. The uncorrected concordance index (c-index) of the nomogram was 0.827 (95% CI, 0.729-0.925) for RFS, and bias-corrected c-index were similar. As compared to TNM stage, the nomogram based on CR provided better discrimination accuracy.

CONCLUSIONS

We demonstrate that CR is a strong prognostic marker to predict structural recurrence in patients with sporadic MTC. The nomogram incorporating CR provided useful prediction of RFS for patients with sporadic MTC to provide personalized treatment.

摘要

背景

降钙素(Ctn)被广泛用作诊断、预后和髓样甲状腺癌(MTC)患者术后随访的标志物。术后降钙素与术前降钙素比值(CR)反映了初始治疗后 Ctn 水平反应的变化,但其在长期疾病结局中的预后价值仍不确定。本研究旨在确定 CR 的截断值以预测结构复发,并评估 CR 在 MTC 患者中的预后作用。

方法

我们回顾性分析了中山大学肿瘤防治中心(SYSUCC) 2000 年至 2022 年间的 MTC 患者。CR 定义为出院当天术后 Ctn 水平与术前 Ctn 水平的比值。为了确定 CR 的最佳截断值,我们进行了受试者工作特征(ROC)分析。我们使用 Kaplan-Meier 方法和 Cox 回归分析评估 CR 对无复发生存率(RFS)的影响。然后,基于 CR 构建了一个列线图。

结果

本研究共纳入 112 例散发性 MTC 患者。预测疾病复发的最佳 CR 截断值为 0.125。CR≥0.125 的患者 RFS 明显差于 CR<0.125 的患者(3 年 RFS 率分别为 63.1%和 94.7%,5 年 RFS 率分别为 50.7%和 90.3%,P<0.001)。在多变量分析中,CR 是结构复发的最强独立预测因子(HR:5.050,95%CI:2.247-11.349,P=0.001)。肿瘤大小(HR:1.321,95%CI:1.010-1.726,P=0.042)、多灶性(HR:2.258,95%CI:1.008-5.058,P=0.048)和转移性淋巴结(HR:3.793,95%CI:1.617-8.897,P=0.001)也是结构复发的独立预测因子。列线图的未校正一致性指数(c-index)为 0.827(95%CI,0.729-0.925),用于 RFS,偏倚校正后的 c-index 相似。与 TNM 分期相比,基于 CR 的列线图提供了更好的区分准确性。

结论

我们证明 CR 是预测散发性 MTC 患者结构复发的有力预后标志物。纳入 CR 的列线图为散发性 MTC 患者的 RFS 提供了有用的预测,为个体化治疗提供了参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe0a/9800993/2dc8c7f58dbc/fendo-13-1094242-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验